1. Home
  2. TENX vs MKTW Comparison

TENX vs MKTW Comparison

Compare TENX & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • MKTW
  • Stock Information
  • Founded
  • TENX 1967
  • MKTW 1999
  • Country
  • TENX United States
  • MKTW United States
  • Employees
  • TENX N/A
  • MKTW N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • MKTW Computer Software: Prepackaged Software
  • Sector
  • TENX Health Care
  • MKTW Technology
  • Exchange
  • TENX Nasdaq
  • MKTW Nasdaq
  • Market Cap
  • TENX 21.7M
  • MKTW 21.2M
  • IPO Year
  • TENX N/A
  • MKTW N/A
  • Fundamental
  • Price
  • TENX $6.30
  • MKTW $0.51
  • Analyst Decision
  • TENX Strong Buy
  • MKTW Hold
  • Analyst Count
  • TENX 3
  • MKTW 1
  • Target Price
  • TENX $16.00
  • MKTW $2.00
  • AVG Volume (30 Days)
  • TENX 20.7K
  • MKTW 492.5K
  • Earning Date
  • TENX 05-13-2025
  • MKTW 05-14-2025
  • Dividend Yield
  • TENX N/A
  • MKTW 13.60%
  • EPS Growth
  • TENX N/A
  • MKTW 260.00
  • EPS
  • TENX N/A
  • MKTW 0.18
  • Revenue
  • TENX N/A
  • MKTW $408,701,000.00
  • Revenue This Year
  • TENX N/A
  • MKTW N/A
  • Revenue Next Year
  • TENX N/A
  • MKTW $15.73
  • P/E Ratio
  • TENX N/A
  • MKTW $2.86
  • Revenue Growth
  • TENX N/A
  • MKTW N/A
  • 52 Week Low
  • TENX $2.77
  • MKTW $0.46
  • 52 Week High
  • TENX $7.89
  • MKTW $1.73
  • Technical
  • Relative Strength Index (RSI)
  • TENX 49.26
  • MKTW 41.88
  • Support Level
  • TENX $6.00
  • MKTW $0.46
  • Resistance Level
  • TENX $6.76
  • MKTW $0.58
  • Average True Range (ATR)
  • TENX 0.40
  • MKTW 0.04
  • MACD
  • TENX 0.02
  • MKTW -0.01
  • Stochastic Oscillator
  • TENX 39.47
  • MKTW 31.08

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About MKTW MarketWise Inc.

Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.

Share on Social Networks: